Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Albuterol in Group 1 Pulmonary Arterial Hypertension
NCT03270332Phase 2Completed
- Sponsor
- University of Miami
- Start
- Oct 2017
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of albuterol dry powder inhaler in pulmonary arterial hypertension (PAH) (2 arms), sponsored by University of Miami. Primary endpoint: Change in Mean Pulmonary Artery Pressure at 30 minutes. Started Oct 2017; status: completed.
02
Drugs
albuterol dry powder inhaler
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03270332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03270332.